Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles is a research paper published in PLoS ONE (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Bill and Melinda Gates Foundation
Grant: INV-036306
MOSTI-PRESIDE
Grant: MOSTI-PRESIDE-COVID-19-2020/15
Medical Research Council
Grant: MC_UU_00033/1
Fields of Study
MeSH Terms